Fibroblast growth-factor-21 is currently a weak biomarker for identifying mitochondrial and non-mitochondrial inborn errors of metabolism

Josef Finsterer 1, * Sinda Zarrouk-Mahjoub 2
* Corresponding author
1 Krankenanstalt Rudolfstiftung
2 LR11IPT05 - Laboratoire de Génomique Biomédicale et Oncogénétique - Biomedical Genomics and Oncogenetics Laboratory
Abstract : Correspondance
Keywords : mtDNA Phenotype Mitochondrial Lymphocytes FGF21 Genotype
Document type :
Journal articles
Complete list of metadatas

Cited literature [2 references]  Display  Hide  Download
https://hal-riip.archives-ouvertes.fr/pasteur-02017153
Contributor : Abdelhakim Ben Hassine <>
Submitted on : Wednesday, February 13, 2019 - 9:06:02 AM
Last modification on : Wednesday, June 26, 2019 - 1:26:46 AM

File

Fibroblast growth.pdf
Publication funded by an institution

Licence

Distributed under a Creative Commons Attribution - NonCommercial - NoDerivatives 4.0 International License

Identifiers

Collections

RIIP | RIIP_TUNIS

Citation

Josef Finsterer, Sinda Zarrouk-Mahjoub. Fibroblast growth-factor-21 is currently a weak biomarker for identifying mitochondrial and non-mitochondrial inborn errors of metabolism. Molecular Genetics and Metabolism Reports, Elsevier, 2018, 14, pp.1-2. ⟨10.1016/j.ymgmr.2017.10.005⟩. ⟨pasteur-02017153⟩

Export

BibTeX TEI DC DCterms EndNote

Share

Metrics

Record views

10

Files downloads

17

Contact

Informations

CCSD